Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H16N6S2 |
| Molecular Weight | 380.49 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N\C(SC1=CC=CC=C1N)=C(C#N)/C(C#N)=C(\N)SC2=C(N)C=CC=C2
InChI
InChIKey=DVEXZJFMOKTQEZ-JYFOCSDGSA-N
InChI=1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+
| Molecular Formula | C18H16N6S2 |
| Molecular Weight | 380.49 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Optical Activity | NONE |
U0126 is a highly selective inhibitor of both MEK1 and MEK2, a type of MAPK/ERK kinase. The inhibitory effects of U0126 on MEK and ERK activation have been confirmed repeatedly, and treatments with U0126 have been shown to inhibit proliferation and migration of cancer cells in vivo and in vitro. U0126 has been widely used as an inhibitor for the Ras/Raf/MEK/ERK signaling pathway. U0126 treatments lead to cancer cell death, which agrees with the well-known role of the Ras/Raf/MEK/ERK pathway in supporting cell survival. U0126 enhances apoptosis in human breast cancer MCF-7 cells, acute myeloid leukemia, and PC12 cells.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Activation of ERK1/2 and p38 kinases by polycyclic aromatic hydrocarbons in rat liver epithelial cells is associated with induction of apoptosis. | 2006-03-15 |
|
| Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. | 2005-12 |
|
| Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. | 2005-10-21 |
|
| 4-Hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells: possible protection by NF-kappaB and ERK/MAPK. | 2005-10-01 |
|
| Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. | 2005-09 |
|
| Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation. | 2005-09 |
|
| Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase. | 2005-08-15 |
|
| Effects of organochlorine insecticides on MAP kinase pathways in human HaCaT keratinocytes: key role of reactive oxygen species. | 2005-08 |
|
| Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells. | 2005-07-29 |
|
| Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. | 2005-07-14 |
|
| Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. | 2005-07-01 |
|
| Investigating the neuroprotective mechanism of action of a CDK5 inhibitor by phosphoproteome analysis. | 2005-07-01 |
|
| Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. | 2005-06-17 |
|
| Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). | 2005-06-15 |
|
| Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. | 2005-06-01 |
|
| 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. | 2005-06 |
|
| Transcriptional profiling of gamma delta T cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands. | 2005-05-15 |
|
| Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. | 2005-05-01 |
|
| Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages. | 2005-05 |
|
| Decrease in cytosolic phospholipase A2alpha mRNA levels by reactive oxygen species via MAP kinase pathways in PC12 cells: effects of dopaminergic neurotoxins. | 2005-05 |
|
| Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation. | 2005-04-15 |
|
| Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes. | 2005-04 |
|
| Doxorubicin induces EGF receptor-dependent downregulation of gap junctional intercellular communication in rat liver epithelial cells. | 2005-03 |
|
| HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage. | 2005-03 |
|
| Fibroblast growth factor-10 prevents asbestos-induced alveolar epithelial cell apoptosis by a mitogen-activated protein kinase-dependent mechanism. | 2005-03 |
|
| Transfected beta3- but not beta2-adrenergic receptors regulate cystic fibrosis transmembrane conductance regulator activity via a new pathway involving the mitogen-activated protein kinases extracellular signal-regulated kinases. | 2005-03 |
|
| ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. | 2005-02-11 |
|
| Disparate expression of IL-12 by SJL/J and B10.S macrophages during Theiler's virus infection is associated with activity of TLR7 and mitogen-activated protein kinases. | 2005-02 |
|
| Role of cell signaling in B[a]P-induced apoptosis: characterization of unspecific effects of cell signaling inhibitors and apoptotic effects of B[a]P metabolites. | 2005-01-15 |
|
| Mesangial cell apoptosis induced by stimulation of the adenosine A3 receptor: signaling and apoptotic events. | 2005-01 |
|
| Stimulation of catecholamine synthesis by environmental estrogenic pollutants. | 2005-01 |
|
| The effect of a brominated flame retardant, tetrabromobisphenol-A, on free radical formation in human neutrophil granulocytes: the involvement of the MAP kinase pathway and protein kinase C. | 2005-01 |
|
| Arsenite regulates Cystic Fibrosis Transmembrane Conductance Regulator and P-glycoprotein: evidence of pathway independence. | 2005 |
|
| Extracellular zinc triggers ERK-dependent activation of Na+/H+ exchange in colonocytes mediated by the zinc-sensing receptor. | 2004-12-10 |
|
| Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line. | 2004-12-01 |
|
| Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma. | 2004-12 |
|
| Plasticity in the entorhinal cortex suppresses memory for contextual fear. | 2004-11-10 |
|
| The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific. | 2004-11-05 |
|
| Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production. | 2004-11-01 |
|
| Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway. | 2004-11 |
|
| Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. | 2004-10-19 |
|
| Asbestos induces tissue factor in Beas-2B cells via PI3 kinase-PKC-mediated signaling. | 2004-10-08 |
|
| Modulation of the transactivation function of nuclear factor-kappaB by lipopolysaccharide in RAW264.7 macrophages. | 2004-10 |
|
| Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. | 2004-10 |
|
| Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. | 2004-08-15 |
|
| Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors. | 2004-07-01 |
|
| Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. | 2004-05-04 |
|
| Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. | 2004-04 |
|
| Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells. | 2004 |
|
| MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. | 2004 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:28:44 GMT 2025
by
admin
on
Mon Mar 31 22:28:44 GMT 2025
|
| Record UNII |
8027P94HLL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2149
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
||
|
FDA ORPHAN DRUG |
593217
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/17/1935
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3006531
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
8027P94HLL
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
109511-58-2
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
DTXSID10892034
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
SUB192758
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
100000177388
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
C1825
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
90693
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
U0126
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY | |||
|
218601-62-8
Created by
admin on Mon Mar 31 22:28:44 GMT 2025 , Edited by admin on Mon Mar 31 22:28:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |